GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (XCNQ:IKNK.U) » Definitions » Notes Receivable

Pideka Group (XCNQ:IKNK.U) Notes Receivable : $0.00 Mil (As of Sep. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Notes Receivable?

Pideka Group's Notes Receivable for the quarter that ended in Sep. 2021 was $0.00 Mil.


Pideka Group Notes Receivable Historical Data

The historical data trend for Pideka Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Notes Receivable Chart

Pideka Group Annual Data
Trend
Notes Receivable

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
Notes Receivable Get a 7-Day Free Trial - - - - -

Pideka Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Pideka Group Notes Receivable Related Terms

Thank you for viewing the detailed overview of Pideka Group's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (XCNQ:IKNK.U) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.

Pideka Group (XCNQ:IKNK.U) Headlines

No Headlines